We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
-3.33%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$9.4B
AUM Growth
-$1.47B
(-14%)
Cap. Flow
-$936M
Cap. Flow
% of AUM
-9.97%
Top 10 Holdings %
Top 10 Hldgs %
27.51%
Holding
1,295
New
171
Increased
621
Reduced
344
Closed
156
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$109M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$60M |
| 3 |
Qualcomm
QCOM
|
+$51.7M |
| 4 |
Texas Instruments
TXN
|
+$40M |
| 5 |
Microsoft
MSFT
|
+$37.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.72B |
| 2 |
Intel
INTC
|
+$70.3M |
| 3 |
KraneShares CSI China Internet ETF
KWEB
|
+$60.1M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$43.5M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.79% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 10.38% |
| 4 | Energy | 7.34% |
| 5 | Consumer Discretionary | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Revolution Medicines
RVMD
$39.9B
| $5.28M | 0.06% |
267,853
+164,852
| +160% | +$3.62M |
|
327
California Resources
CRC
$4.67B
| $5.24M | 0.06% |
136,391
-93,636
| -41% | -$4.07M |
|
328
Factset
FDS
$9.36B
| $5.23M | 0.06% |
13,074
+1,021
| +8% | +$432K |
|
329
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.28B
| $5.22M | 0.06% |
288,607
-6,126
| -2% | -$129K |
|
|
CPRX
330
DELISTED
Catalyst Pharmaceutical
CPRX
| $5.19M | 0.06% |
404,709
+218,609
| +117% | +$2.59M |
|
331
Roper Technologies
ROP
$38.8B
| $5.14M | 0.05% |
14,306
+1,994
| +16% | +$811K |
|
332
Pultegroup
PHM
$24.1B
| $5.1M | 0.05% |
135,964
-4,847
| -3% | -$204K |
|
333
Zions Bancorporation
ZION
$10.2B
| $5.09M | 0.05% |
100,117
+18,358
| +22% | +$1M |
|
334
iShares Global Clean Energy ETF
ICLN
$2.31B
| $5.07M | 0.05% |
265,617
+46,520
| +21% | +$992K |
|
335
Travere Therapeutics
TVTX
$5.2B
| $5.07M | 0.05% |
205,767
+72,542
| +54% | +$1.87M |
|
|
VTNR
336
DELISTED
Vertex Energy, Inc
VTNR
| $5.07M | 0.05% |
813,735
+123,434
| +18% | +$1.13M |
|
337
Motorola Solutions
MSI
$72.3B
| $4.99M | 0.05% |
22,280
+3,035
| +16% | +$716K |
|
338
CareDx
CDNA
$2.26B
| $4.97M | 0.05% |
291,945
+123,736
| +74% | +$2.66M |
|
339
Allogene Therapeutics
ALLO
$649M
| $4.97M | 0.05% |
459,831
+237,972
| +107% | +$3.23M |
|
340
Emergent Biosolutions
EBS
$373M
| $4.93M | 0.05% |
234,983
+107,256
| +84% | +$2.98M |
|
341
Cincinnati Financial
CINF
$27.3B
| $4.9M | 0.05% |
54,692
+5,018
| +10% | +$517K |
|
342
Brown & Brown
BRO
$23.6B
| $4.87M | 0.05% |
80,519
+5,437
| +7% | +$342K |
|
343
TransDigm Group
TDG
$70.2B
| $4.81M | 0.05% |
9,164
+522
| +6% | +$311K |
|
344
TE Connectivity
TEL
$59.6B
| $4.72M | 0.05% |
42,759
+5,701
| +15% | +$710K |
|
|
SRNE
345
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $4.7M | 0.05% |
2,994,674
+1,243,608
| +71% | +$2.82M |
|
346
Synchrony
SYF
$24.7B
| $4.7M | 0.05% |
+166,586
| New | +$5.38M |
|
347
Northern Oil and Gas
NOG
$2.3B
| $4.69M | 0.05% |
171,092
-78,802
| -32% | -$2.23M |
|
348
TG Therapeutics
TGTX
$7.96B
| $4.58M | 0.05% |
773,210
+161,805
| +26% | +$1.06M |
|
349
Textron
TXT
$14.7B
| $4.56M | 0.05% |
78,262
-4,824
| -6% | -$306K |
|
350
W.R. Berkley
WRB
$26.9B
| $4.53M | 0.05% |
105,239
+7,164
| +7% | +$311K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, Rafferty Asset Management held 1,295 positions worth $9.4B, down 14% from $10.9B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Rafferty Asset Management withdrew a net $936M in Q3 2022, closing 156 positions and reducing 344 holdings. Its most notable exit was iShares Russell 1000 Value ETF, an estimated $21.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Rafferty Asset Management opened a new position in American Express worth $28M.
- Rafferty Asset Management's largest Q3 2022 buy was American Express: 207,400 shares worth $28M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q3 2022, an estimated $109M increase.
- Rafferty Asset Management's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.72B.
- Rafferty Asset Management fully exited iShares Russell 1000 Value ETF in Q3 2022, selling an estimated $21.8M.
- Rafferty Asset Management's ten largest holdings make up 28% of its $9.4B portfolio in Q3 2022.
- Rafferty Asset Management opened 171 new positions and closed 156 in Q3 2022.
- Rafferty Asset Management's portfolio value fell 14% quarter-over-quarter to $9.4B.
Based on Rafferty Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.